Log in

LON:HNTHuntsworth Share Price, Forecast & News

GBX 2,500
0.00 (0.00 %)
(As of 06/9/2020)
Today's Range
Now: GBX 2,500
50-Day Range
MA: GBX 298.90
52-Week Range
Now: GBX 2,500
Volume30,000 shs
Average Volume1.01 million shs
Market Capitalization£9.29 billion
P/E Ratio462.96
Dividend Yield2.42%
Huntsworth plc, together with its subsidiaries, operates as a healthcare and communications company in the United Kingdom and rest of Europe, the United States, and internationally. The company operates through four divisions: Medical, Marketing, Immersive, and Communications. The Medical division provides scientific strategy and communications, publications planning and delivery, specialized medical writing, medical education, and payer and value communications services, as well as support services for internal medical teams. This division serves pharmaceutical and biotechnology clients. The Marketing division markets prescription drugs to consumers and healthcare professionals; and provides healthcare public relations agency and payer marketing services. This segment serves biotech and pharma, OTC, wellness, and lifestyle brands. The Immersive division creates and delivers live experiences, and scientific and interactive contents; creates and produces various films, including short and internal engagement films, documentaries, and action demonstrations; develops immersive experiences for employees training and explaining complex science; and designs strategic and creative programs to engage internal audiences. This division primarily serves healthcare industry. The Communications division provides public relations and affairs, and investor relations solutions; and communication consulting services primarily for cross-border financial transactions and multinationals to broaden their global footprint, as well as develops and manages campaigns, runs press offices, and steers brands and businesses through engagement with media, consumers, customer stakeholders, and internal audiences. The company was formerly known as Holmes & Marchant Group plc and changed its name to Huntsworth plc in July 1999. Huntsworth plc was incorporated in 1983 and is headquartered in London, the United Kingdom.
Read More
Huntsworth logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.3Community Rank: 2.7Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.13 out of 5 stars

Industry, Sector and Symbol

Industry Advertising Agencies



Sales & Book Value

Annual Sales£264.85 million
Cash FlowGBX 141.86 per share
Book ValueGBX 49.80 per share



Market Cap£9.29 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive HNT News and Ratings via Email

Sign-up to receive the latest news and ratings for HNT and its competitors with MarketBeat's FREE daily newsletter.

Huntsworth (LON:HNT) Frequently Asked Questions

How has Huntsworth's stock been impacted by COVID-19 (Coronavirus)?

Huntsworth's stock was trading at GBX 106 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, HNT stock has increased by 2,258.5% and is now trading at GBX 2,500. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Huntsworth?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Huntsworth in the last year. There are currently 3 hold ratings, 1 buy rating and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Huntsworth.

How were Huntsworth's earnings last quarter?

Huntsworth plc (LON:HNT) issued its earnings results on Tuesday, July, 24th. The company reported $2.60 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $2.80 by $0.20. View Huntsworth's earnings history.

How often does Huntsworth pay dividends? What is the dividend yield for Huntsworth?

Huntsworth declared a dividend on Tuesday, March 3rd. Stockholders of record on Thursday, August 6th will be given a dividend of GBX 1.85 per share on Friday, September 18th. This represents a yield of 1.74%. The ex-dividend date of this dividend is Thursday, August 6th. The official announcement can be seen at this link. View Huntsworth's dividend history.

What price target have analysts set for HNT?

5 brokers have issued 12-month target prices for Huntsworth's stock. Their forecasts range from GBX 108 to GBX 135. On average, they expect Huntsworth's stock price to reach GBX 117.75 in the next twelve months. This suggests that the stock has a possible downside of 95.3%. View analysts' price targets for Huntsworth.

Has Huntsworth been receiving favorable news coverage?

Press coverage about HNT stock has been trending negative this week, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Huntsworth earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about Huntsworth.

Who are some of Huntsworth's key competitors?

What other stocks do shareholders of Huntsworth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Huntsworth investors own include Derwent London (DLN), Oracle (ORCL), IP Group (IPO), Legal & General Group (LGEN), London Stock Exchange Group (LSE), Petrofac (PFC), Plus500 (PLUS), Ashtead Group (AHT), Agios Pharmaceuticals (AGIO) and Celgene (CELG).

Who are Huntsworth's key executives?

Huntsworth's management team includes the following people:
  • Mr. Paul Taaffe, CEO & Director
  • Mr. Neil Garth Jones, CFO & Director (Age 53)
  • Mr. Tom Chandos, Head of Media Sector - Grayling (Age 66)
  • Mr. Martin Morrow, Company Sec.

What is Huntsworth's stock symbol?

Huntsworth trades on the London Stock Exchange (LON) under the ticker symbol "HNT."

How do I buy shares of Huntsworth?

Shares of HNT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Huntsworth's stock price today?

One share of HNT stock can currently be purchased for approximately GBX 2,500.

How big of a company is Huntsworth?

Huntsworth has a market capitalization of £9.29 billion and generates £264.85 million in revenue each year. Huntsworth employs 1,903 workers across the globe.

What is Huntsworth's official website?

The official website for Huntsworth is www.huntsworth.com.

How can I contact Huntsworth?

Huntsworth's mailing address is 8th Fl Holborn Gate, 26 Southampton Buildings, LONDON, WC2A 1AN, United Kingdom. The company can be reached via phone at +44-20-72248778.

This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.